Pharmaceuticals

Pharmaceuticals Clinical Trials Patient Care Medical Research Clinical Research Stock Market Drug Development Pharmaceuticals Public Health Medical Treatments

6 ARTICLES

15h ago

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer

Phase III data validate December’s accelerated FDA decision by confirming the encorafenib, cetuximab and mFOLFOX6 combination as a new standard of care for this aggressive molecularly defined disease.

Stories older than 24h

4 ARTICLES

yesterday

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

3 ARTICLES

yesterday

New AF4-ICP-MS method quantifies ionic and nanoparticle metals in nanomedicines

3 ARTICLES

2d ago

Sotatercept cuts risk of death and hospitalization by 76% in advanced pulmonary arterial hypertension

3 ARTICLES

2d ago

JM2 Peptide Disrupts Glioblastoma Stem Cells and Slows Tumor Growth in Preclinical Models

5 ARTICLES

3d ago

Three Arrested in Selby Over Illegal Slimming Injections After Woman's Hospitalisation

4 ARTICLES

last wk.

Australia Approves Donanemab as First Disease-Modifying Alzheimer’s Therapy

4 ARTICLES

last wk.

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

11 ARTICLES

last wk.

Health Secretary Urges Faster NHS Rollout of Weight-Loss Injections

8 ARTICLES

last wk.

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

3 ARTICLES

last wk.

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

5 ARTICLES

last wk.

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

16 ARTICLES

2w ago

FDA Approves First Blood Test for Alzheimer’s Diagnosis

12 ARTICLES

2w ago

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Particle.news

Pharmaceuticals

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

New AF4-ICP-MS method quantifies ionic and nanoparticle metals in nanomedicines

Sotatercept cuts risk of death and hospitalization by 76% in advanced pulmonary arterial hypertension

JM2 Peptide Disrupts Glioblastoma Stem Cells and Slows Tumor Growth in Preclinical Models

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications

Never miss stories about

Pharmaceuticals

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

Three Arrested in Selby Over Illegal Slimming Injections After Woman's Hospitalisation

Australia Approves Donanemab as First Disease-Modifying Alzheimer’s Therapy

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

Health Secretary Urges Faster NHS Rollout of Weight-Loss Injections

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

FDA Approves First Blood Test for Alzheimer’s Diagnosis

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Never miss stories about

Pharmaceuticals